MODERN DIRECTED ANTIVIRAL COVID-19 THERAPY: RESULTS OF MULTICENTER CLINICAL EFFECTIVENESS AND SAFETY STUDY OF FIXED NIRMATRELVIR+RITONAVIR COMBINATION

MODERN DIRECTED ANTIVIRAL COVID-19 THERAPY: RESULTS OF MULTICENTER CLINICAL EFFECTIVENESS AND SAFETY STUDY OF FIXED NIRMATRELVIR+RITONAVIR COMBINATION

The article presents the data from an open, two-stage, multicenter study on the efficacy and safety evaluation of a combined drug (a fixed combination of nirmatrelvir 300 mg and ritonavir 100 mg) in the complex therapy in COVID-19 patients.The aim of the study was to assess the safety, tolerability...

Full description

Saved in:
Bibliographic Details
Main Authors: L. A. Balykova, N. M. Selezneva, E. I. Gorshenina, O. I. Shepeleva, N. V. Kirichenko, E. N. Simakina, K. B. Kolontarev, D. Yu. Pushkar, D. N. Zemskov, K. Ya. Zaslavskaya, S. M. Noskov, A. V. Taganov, P. A. Bely
Format: Article
Language:Russian
Published: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2022-10-01
Series:Фармация и фармакология (Пятигорск)
Subjects:
coronavirus
covid-19
nirmatrelvir
ritonavir
skyvira®
adverse events
Online Access:https://www.pharmpharm.ru/jour/article/view/1167
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.pharmpharm.ru/jour/article/view/1167

Similar Items